Drugs / 17DD Yellow Fever vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03132311 | May 2017 → Dec 2018 overdue | HIV infectious disease | Oswaldo Cruz Foundation | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 17DD Yellow Fever vaccine | “the 17DD Yellow Fever vaccine in HIV infected individuals” NCT03132311 ↗ |
| Modality | Vaccine | “the 17DD Yellow Fever vaccine in HIV infected individuals” NCT03132311 ↗ |
| Route | Intramuscular | “One intramuscular injection” NCT03132311 ↗ |